Logo image of BAYAR

BAYVIEW ACQUISITION CORP (BAYAR) Stock Price, Quote, News and Overview

NASDAQ:BAYAR - Nasdaq - KY07323B1189 - Currency: USD

0.1358  0 (-0.07%)

Fundamental Rating

1

Taking everything into account, BAYAR scores 1 out of 10 in our fundamental rating. BAYAR was compared to 0 industry peers in the Unkown industry. Both the profitability and financial health of BAYAR have multiple concerns. BAYAR does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year BAYAR was profitable.
In the past year BAYAR has reported a negative cash flow from operations.
BAYAR Yearly Net Income VS EBIT VS OCF VS FCFBAYAR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 0 20K -20K 40K 60K 80K

1.2 Ratios

Industry RankSector Rank
ROA 4.77%
ROE 5.13%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BAYAR Yearly ROA, ROE, ROICBAYAR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 0 0.05 0.1

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for BAYAR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BAYAR Yearly Profit, Operating, Gross MarginsBAYAR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023

More info and screens

1

2. Health

2.1 Basic Checks

There is no outstanding debt for BAYAR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BAYAR Yearly Shares OutstandingBAYAR Yearly Shares OutstandingYearly Shares Outstanding 2023 2M 4M 6M
BAYAR Yearly Total Debt VS Total AssetsBAYAR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 20M 40M 60M

2.2 Solvency

BAYAR has an Altman-Z score of 0.02. This is a bad value and indicates that BAYAR is not financially healthy and even has some risk of bankruptcy.
A Debt/Equity ratio of 0.00 indicates that BAYAR is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.02
ROIC/WACCN/A
WACCN/A
BAYAR Yearly LT Debt VS Equity VS FCFBAYAR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 0 10M 20M 30M 40M 50M

2.3 Liquidity

A Current Ratio of 0.49 indicates that BAYAR may have some problems paying its short term obligations.
BAYAR has a Quick Ratio of 0.49. This is a bad value and indicates that BAYAR is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.49
Quick Ratio 0.49
BAYAR Yearly Current Assets VS Current LiabilitesBAYAR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 20M 40M 60M

More info and screens

0

3. Growth

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8512.22%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BAYAR Yearly Revenue VS EstimatesBAYAR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023
BAYAR Yearly EPS VS EstimatesBAYAR Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

BAYAR is valuated cheaply with a Price/Earnings ratio of 0.57.
BAYAR's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 29.62.
Industry RankSector Rank
PE 0.57
Fwd PE N/A
BAYAR Price Earnings VS Forward Price EarningsBAYAR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BAYAR Per share dataBAYAR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

BAYAR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BAYVIEW ACQUISITION CORP

NASDAQ:BAYAR (2/21/2025, 8:02:44 PM)

0.1358

0 (-0.07%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners72.53%
Inst Owner Change-88.8%
Ins Owners7.03%
Ins Owner ChangeN/A
Market Cap738.75K
AnalystsN/A
Price TargetN/A
Short Float %0.01%
Short Ratio0.04
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 0.57
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.02
P/tB 0.02
EV/EBITDA N/A
EPS(TTM)0.24
EY176.73%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)-0.07
OCFYN/A
SpS0
BVpS6.68
TBVpS6.68
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.77%
ROE 5.13%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.49
Quick Ratio 0.49
Altman-Z 0.02
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8512.22%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A